Publicacions en col·laboració amb investigadors/es de Complejo Asistencial Universitario de León (10)

2020

  1. Efficacy and safety of immunomodulatory drugs in patients with non-infectious intermediate and posterior uveitis, panuveitis and macular edema: A systematic literature review

    Seminars in Arthritis and Rheumatism, Vol. 50, Núm. 6, pp. 1299-1306

  2. Recommendations statement on the immunosuppressive treatment of non-infectious, non-neoplastic, non-anterior uveitis

    Medicina Clinica, Vol. 155, Núm. 5, pp. 220.e1-220.e12

2019

  1. Comparative Study of Infliximab Versus Adalimumab in Refractory Uveitis due to Behçet's Disease: National Multicenter Study of 177 Cases

    Arthritis and Rheumatology, Vol. 71, Núm. 12, pp. 2081-2089

  2. Spanish Registry of Recent-onset Psoriatic Arthritis (REAPSER study): Aims and methodology

    Reumatologia Clinica, Vol. 15, Núm. 5, pp. 252-257

2018

  1. Recommendations for the use of parenteral methotrexate in rheumatic diseases

    Reumatologia Clinica, Vol. 14, Núm. 3, pp. 142-149

  2. Successful Optimization of Adalimumab Therapy in Refractory Uveitis Due to Behçet's Disease

    Ophthalmology, Vol. 125, Núm. 9, pp. 1444-1451

2017

  1. Efficacy and safety of immunomodulatory drugs in patients with anterior uveitis

    Medicine (United States), Vol. 96, Núm. 42

  2. Treatment recommendations for non-infectious anterior uveitis

    Medicina Clinica, Vol. 149, Núm. 12, pp. 552.e1-552.e12

2016

  1. Relationship between damage clustering and mortality in systemic lupus erythematosus in early and late stages of the disease: Cluster analyses in a large cohort from the Spanish Society of Rheumatology Lupus Registry

    Rheumatology (United Kingdom), Vol. 55, Núm. 7, pp. 1243-1250

  2. Urine metabolome profiling of immune-mediated inflammatory diseases

    BMC Medicine, Vol. 14, Núm. 1